10 Recommendations for Global Kidney Health

10 Recommendations for Global Kidney Health

At the Global Kidney Policy Forum 2017, stakeholders interested in addressing the growing burden of kidney disease to the global community gathered to describe, discuss and develop a set of recommendations to guide future efforts to reduce the burden of kidney disease worldwide, with a specific emphasis on Latin America. The following points, updated and condensed in 2023, constitute a commitment from all the stakeholders to address the increasing burden of people living with kidney disease.

 

  1. Work toward prevention, early diagnosis, treatment and management of kidney diseases.

Managing risk factors can help to keep healthy kidneys, as well as to slow down the progression of already developed diseases. In order to prevent and manage AKI and CKD in adults and children, public health policies need to be developed which have to:

  • Ensure healthy adult, maternal and child lifestyles and nutrition.
  • Reduce the burden of co-occurring conditions such as diabetes, hypertension, cardiovascular diseases and/or obesity.
  • Reduce unhealthy addictions burden from drugs, tobacco, and/or alcohol.
  • Promote safe work environments and assist in situations that threaten safety and/or security (such as natural hazards or violence). Strategies that include medications, kidney replacement therapy (KRT), promote recovery and prevent recurrence need to be created.
  • Prevent and respond to epidemic and endemic infectious diseases that impact kidney health.

 

  1. Monitor the burden of kidney diseases.

To better understand the burden of AKI and CKD data is needed, therefore:

  • surveillance programs need to be implemented and supported to better understand the global burden of AKI and CKD within and outside the context of non-communicable diseases.
  • robust national and regional registries on the incidence, prevalence and aetiology of AKI, CKD, and kidney failure with or without KRT need to be developed.

 

  1. Raise public awareness of kidney diseases.

Improved health literacy among patients on kidney disease and its risk factors would empower patients in decision-making and self-management of their conditions. Understanding the association of kidney disease with other non-communicable diseases as well as the risk factors that may lead to developing kidney needs to be deepened. This could be achieved through multiple approaches such as informational campaigns paired with primary care, and community health centres.

 

  1. Address kidney diseases across the life course through universal health coverage.

Universal health coverage (UHC) ensures that all individuals receive quality health services, from health promotion to rehabilitation, from treatment to palliative care, depending on their needs and without financial burden throughout their life-course. For optimal kidney health, this begins with universal access to antenatal care and child health visits, and permits sustainable access to effective and affordable quality diagnostics and medications for detecting and treating risk factors, such as hypertension, diabetes, cardiovascular and urologic diseases. This helps to delay kidney disease progression.  

 

  1. Integrate kidney disease services within existing health and multisectoral initiatives.

There is a need for a stronger push to ensure integration and synergies for kidney disease prevention and treatment within existing health and multisectoral initiatives. Policies should be developed and implemented to serve as the needed push. They should be developed following the current frameworks promoted by the World Health Organization and the United Nations such as:

 

  1. Close education gaps on kidney diseases among all healthcare workers.

Knowledge of kidney disease needs to be deepened among healthcare workers at all levels. This ensures that a lack of clinical awareness does not become a barrier for patients to get appropriate access to essential tools and medications required for protection, diagnosis, and treatment to prevent kidney injury and failure.

 

  1. Invest in strengthening the kidney care workforce.

Supporting education and the growth of a skilled nephrology workforce is needed to ensure the highest level of patient care across the spectrum of kidney diseases. The nephrology workforce needs to be confident when implementing screening, prevention, and treatment of kidney disease from its early acute stage to its chronic stages. This includes using kidney replacement therapy, conservative management and palliative care.

 

  1. Strive towards equitable and sustainable access to care for kidney failure.

Develop and implement policies that ensure equitable access to kidney disease care for all, regardless of gender, income or ethnicity. Everyone needs to have access to:

  • Early diagnosis of kidney disease.
  • Appropriate treatment.
  • Kidney replacement therapies and transplantation.

Additionally, safe, ethical, affordable, and sustainable programs that are appropriate to each region’s cultural, religious, and social context need to be supported. Programs should incorporate quality metrics and processes to ensure accountability.

 

  1. Promote and expand kidney transplantation programs.

Transplantation programs need to be promoted and expanded across the globe. These programs must equal access to transplantation regardless of an individual’s income and uphold ethical practice in management of all donors and recipients. The integration of such programs must be respectful, recognising each region’s cultural characteristics. Adherence to the principles of the Declaration of Istanbul should be universal. Programs should incorporate quality metrics and processes to ensure accountability.

 

  1. Support research for kidney diseases.

Local, regional, and collaborative international research in acute kidney injury (AKI) and chronic kidney disease (CKD) needs to be supported. This would deepen understanding of kidney disease, which would eventually lead to better prevention and treatment strategies. Ethical principles in the conduct of research are critical. For advancing in this field:

  • Publishing research work in mainstream journals needs to be promoted and facilitated.
  • To advance the research and treatment of kidney diseases, human resources in the academic and medical workforce must be increased and supported.

 

English version

News

The ISN Joined European Event to Celebrate 80th Anniversary of Dialysis

As a European Kidney Health Alliance (EKHA) member, the ISN was pleased to participate in the film screening and roundtable, "Celebrating 80 Years for Dialysis: Time Again for Science-Fiction to Meet Reality," organized by the EKHA at the European Parliament in Brussels on April 26, 2023. Hosted by MEPs Ondřej Knotek and Martin Buschmann, co-chair of the MEP...

ISN Constituency Statement – Well-being and health promotion – at WHA76

76th World Health Assembly Distinguished delegates, We welcome the development of WHO's global framework on well-being, commending the recognition that addressing the main NCD risk factors (including tobacco, alcohol, unhealthy diets, physical inactivity and air pollution), and their root causes, is a foundation of well-being, and that health promotion is an essential public health function and Universal...

Four Statements and a Stand-alone Event – the ISN Advocates for Better Kidney Health for All at the 76th World Health Assembly

Four Statements and a Stand-alone Event - the ISN Advocates for Better Kidney Health at the 76th World Health Assembly The ISN is pleased to announce its participation at the 76th World Health Assembly (WHA) in Geneva from May 21 to 30, 2023. Working alongside partners in the NCD Alliance and the World Heart Federation,...

ISN Constituency Statement – Draft updated menu of policy options and cost-effective interventions for the prevention and control of NCDs – at WHA76

76th World Health Assembly Distinguished delegates, We welcome the updated Appendix 3 of the Global NCD Action Plan, and we also support the statement led by UICC. In particular, we commend the expansion of cost-effectiveness analyses to new interventions, parameters, and country data, which reinforces their investment case. More specifically, we applaud: The changes made to healthy diets...